Professor Dajani provides litigation support and testimony for plaintiff and defense in the fields of drug injury causations, drug-related medical malpractice, pharmacy malpractice, medication errors, Cytotec®, pharmaceutical patent litigations, drug product liability (e.g., warnings, designs, formulations & labeling), complementary drugs, beauty products, industrial chemicals, forensic aspects of drug intoxications and contract research organizations (CROs). The services include investigations, research, record analysis, consultation, merit statement and testimony.
Professor Dajani has broad experience in clinical pharmacology, toxicology, regulatory affairs and drug development. He was most instrumental in the discovery and development of Cytotec®, a worldwide anti-ulcer drug. He is the president of the IDDC Corporation, a CRO which provides scientific consulting services for pharmaceutical companies, law firms and US governmental agencies. He concurrently held academic appointments in Pharmacology and in Medicine. Currently, he holds Adjunct Professor of Medicine appointment at Loyola University-Chicago.